Fall 2024 Vol. 14 Issue 03
-
From the Editor-in-Chief
Innovative Therapy Takes a BiTE Out of CancerBispecific T-cell engagers (BiTEs) bring immune cells close enough to cancer cells to destroy them.
by William G. Nelson, MD, PhD
-
-
Your Cancer Guide
Relationship WoesA cancer diagnosis can tax even the healthiest of relationships, exposing once invisible cracks in your relationship's foundation.
by Hester Hill Schnipper
-
Caregiving With Confidence
What’s for Dinner?Planning ahead can help ensure caregivers have healthy food options on hand.
by K.J. Bannan
-
Policy Matters
The Future of Perioperative Clinical Trial DesignsA recent FDA-AACR workshop explored best practices for trial design, analysis and interpretation of clinical studies with multiple phases of treatment.
by Elizabeth M. Jaffee, MD
-
Breast Cancer: Making Treatment DecisionsWith additional treatment options and an emphasis on reducing side effects, patients with breast cancer have more decisions to make than ever before.
by Natalie Slivinski
-
Patients as Research PartnersNew platforms allow patients to share their clinical data and tumor tissue no matter where they live, offering everyone a chance to participate in research.
by Erin O'Donnell
-
The Push for Inclusive Cancer CarePeople with intellectual or developmental disabilities face obstacles to receiving appropriate cancer screening and treatment. Advocates are calling on the health care system to meet their needs and increase access to care.
by Thomas Celona
-
Survivor Profile
From Fear to ActionMike Herman hasn’t let a multiple myeloma diagnosis stop him from advocating for himself and teaching others to do the same.
by Suzanne McBride
-
-
Q&A
The Voices of ‘Cancering’Oncologist Jennifer Young Pierce hosts a podcast that aims to demystify cancer and inspire people touched by the disease.
by Tyler Santora
-
-
Get Involved
Happy FeetThe HallieStrong Foundation sends people receiving cancer treatment socks designed to put smiles on their faces.
by Thomas Celona
-
Facts and Stats
Treatment Advances Help Fuel Survival IncreasesPeople with localized esophageal cancer and advanced melanoma have benefited from improved cancer care.
by Thomas Celona
U.S. breast cancer deaths declined for women ages 20 to 49, which researchers credit to wider screening and better treatment.
by Kevin McLaughlin
Missed Activities Due to Cancer-related Fatigue and DepressionWomen were more likely than men to have fatigue or depression linked to cancer, and both effects were linked to people withdrawing from physical activities.
by Eric Fitzsimmons
Immunotherapy Improves Results in Head and Neck CancerCombining an immune checkpoint inhibitor with standard care extended event-free survival by nearly two years.
by Thomas Celona
Federal Support for Cancer Research Takes the Stage at AACR Annual MeetingScientists and former administrators gather for session focused on advocating for cancer research in uncertain times.
by Kevin McLaughlin
-
Inaugural AACR IO Conference Kicks Off With Celebration of Immune CheckpointsImmune checkpoint icons James Allison and Arlene Sharpe shared their journeys and a look ahead on the opening night of the inaugural AACR IO conference.
-
A New Resource Provides a Sanctuary for Black TNBC PatientsThe Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
